BDC vs REGN · P/E 24, rev $2.72B vs P/E 14, rev $14.34B
Belden Inc (BDC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Belden Inc (BDC) is a communication equipment company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BDC revenue for 2025-12-31 was $2.72B. Net income was $237.5M. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. BDC currently screens at market cap $4.84B and trailing P/E 23.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BDC currently screens at market cap $4.84B and trailing P/E 23.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BDC and REGN stock pages for the full models.
Not investment advice.